Literature DB >> 3312844

Abnormalities of the short arm of chromosome 9 with partial loss of material in hematological disorders.

C Pollak1, A Hagemeijer.   

Abstract

Clinical, hematological, and cytogenetic data of 32 patients with loss of part of the short arm of chromosome 9 (9p-) are reviewed. There were 20 acute lymphoblastic leukemia (ALL), seven non-Hodgkin lymphoma (NHL), three acute myeloid leukemia, one refractory anemia with excess blasts in transformation, and one chronic myeloid leukemia (CML) in blast crisis. The cytogenetic findings were heterogeneous: 13 cases of del(9)(p21), among them four as sole karyotypic change; five cases of del(9)(p12), three of them as sole karyotypic change; four patients with i(9q), three with unbalanced translocations involving 9p12; and seven with unbalanced translocations involving 9p21. In addition, 10 patients showed known specific translocations for determined subgroups of ALL, NHL, and CML. The immunological phenotypes in the 20 ALL patients were common ALL (35%), pre-B-ALL (35%), B-ALL (5%), T-ALL (15%), and null ALL (10%). Three NHL were of T cell origin and the others of B cell origin. No specific association between the karyotypic change, immunophenotype, and clinical presentation could be ascertained for patients with ALL, acute myeloid leukemia, CML in blast crisis, and B-NHL. In T-NHL, three children with deletion of 9p, T immunoblastic lymphoma originating from common thymocyte and presenting with a mediastinal mass and pleural effusion may constitute a definite subgroup with good prognosis. All other cases had a poor outcome. Previously suggested association of 9p- with T-ALL and "lymphomatous features" was not confirmed.

Entities:  

Mesh:

Year:  1987        PMID: 3312844

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  9 in total

1.  A polymorphic region defined by pCN2 (the 3' nontranslated region of N-ras) maps to chromosome 9cen-p12.

Authors:  T Nobori; L E Hexdall; D A Carson
Journal:  Hum Genet       Date:  1991-08       Impact factor: 4.132

2.  Breakpoint junctions of chromosome 9p deletions in two human glioma cell lines.

Authors:  H M Pomykala; S K Bohlander; P L Broeker; O I Olopade; M O Díaz
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

Review 3.  STAT signaling in the pathogenesis and treatment of cancer.

Authors:  D A Frank
Journal:  Mol Med       Date:  1999-07       Impact factor: 6.354

4.  Isochromosome 9q as a sole anomaly in an Omani boy with acute lymphoblastic leukaemia.

Authors:  Udayakumar Muthappa Achandira; Anil V Pathare; Salam Al Kindi; David Dennison; Said Al Yahyaee
Journal:  BMJ Case Rep       Date:  2009-04-28

5.  Acute myeloid leukemia with t(10;17)(p13;q12) chromosome translocation: a case report and literature review.

Authors:  Lu Li; Fan Zhou; Jian Hou
Journal:  Am J Blood Res       Date:  2012-11-25

6.  Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines.

Authors:  M O Diaz; S Ziemin; M M Le Beau; P Pitha; S D Smith; R R Chilcote; J D Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

7.  Acquired pericentric inversion of chromosome 9 in acute myeloid leukemia.

Authors:  A M Udayakumar; A V Pathare; D Dennison; J A Raeburn
Journal:  J Appl Genet       Date:  2009       Impact factor: 3.240

8.  The use of ultra-dense array CGH analysis for the discovery of micro-copy number alterations and gene fusions in the cancer genome.

Authors:  Ewa Przybytkowski; Cristiano Ferrario; Mark Basik
Journal:  BMC Med Genomics       Date:  2011-01-27       Impact factor: 3.063

9.  Deletion 9p23 to 9p11.1 as sole additional abnormality in a Philadelphia positive chronic myeloid leukemia in blast crisis: a rare event.

Authors:  Abdulsamad Wafa; Manar Asa'ad; Adnan Ikhtiar; Thomas Liehr; Walid Al-Achkar
Journal:  Mol Cytogenet       Date:  2015-08-04       Impact factor: 2.009

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.